Trainee Pearls podcast

#18 Jurjen Versluis: Transplant for high-risk MDS

29/10/2023
0:00
20:34
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival. The authors evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. https://pubmed.ncbi.nlm.nih.gov/37607457/ ALSO AS VIDEO ON https://youtu.be/JbHS_-2sJQc CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/CarmeloGurnari


Altri episodi di "Trainee Pearls"